BioSpace News Archive

Drug Development

Marshall Edwards, Inc.'s Compound Triphendiol May Aid in Treatment of Pancreatic Cancer

March 25, 2008
·
6 min read
Drug Development

Novogen Limited Compound NV-128 Uses mTOR Pathway to Induce Cell Death in Chemo-Resistant Ovarian Cancer Cells

March 25, 2008
·
2 min read
Business

Ceragenix Pharmaceuticals, Inc. Enters into Agreement to License CSA-54 and other Ceragenin Compounds for HIV and STD Applications

March 25, 2008
·
6 min read
Drug Development

Chelsea Therapeutics, Inc. Reports Significant Efficacy of CH-4051 in Reduction of Collagen-Induced Arthritis in Animal Model

March 25, 2008
·
3 min read
FDA

Regeneron Pharmaceuticals, Inc.'s ARCALYST(TM), First and Only FDA-approved Treatment for Cryopyrin-Associated Periodic Syndromes, Now Available in the United States

March 25, 2008
·
7 min read
Drug Development

Celgene’s Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer

March 25, 2008
·
3 min read
Deals

Bio-Imaging Technologies, Inc. Buys Data Services Provider for $24M

March 25, 2008
·
7 min read
Business

Galil Medical Inc. Announces the Appointment of CEO

March 25, 2008
·
2 min read
Business

Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals

March 25, 2008
·
3 min read
Drug Development

Anesiva, Inc. Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy

March 25, 2008
·
7 min read